SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010798
Filing Date
2019-11-12
Accepted
2019-11-12 16:04:18
Documents
73
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20190930x10qc6fb6d.htm   iXBRL 10-Q 2143135
2 EX-10.1 ex-10d1.htm EX-10.1 283625
3 EX-10.2 ex-10d2.htm EX-10.2 78992
4 EX-31.1 ex-31d1.htm EX-31.1 19679
5 EX-31.2 ex-31d2.htm EX-31.2 19204
6 EX-32.1 ex-32d1.htm EX-32.1 13500
7 GRAPHIC ex-10d1g001.jpg GRAPHIC 2013
8 GRAPHIC ex-10d1g002.jpg GRAPHIC 723
9 GRAPHIC ex-10d2g001.jpg GRAPHIC 2429
10 GRAPHIC ex-10d2g002.jpg GRAPHIC 2429
  Complete submission text file 0001558370-19-010798.txt   7599388

Data Files

Seq Description Document Type Size
11 EX-101.SCH edit-20190930.xsd EX-101.SCH 45116
12 EX-101.CAL edit-20190930_cal.xml EX-101.CAL 51448
13 EX-101.DEF edit-20190930_def.xml EX-101.DEF 160052
14 EX-101.LAB edit-20190930_lab.xml EX-101.LAB 445700
15 EX-101.PRE edit-20190930_pre.xml EX-101.PRE 328320
71 EXTRACTED XBRL INSTANCE DOCUMENT edit-20190930x10qc6fb6d_htm.xml XML 1197334
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 191209247
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences